C M Bidwell & Associates LTD Zoetis Inc. Transaction History

C M Bidwell & Associates LTD

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$144.0 - $169.39 $87,264 - $102,650	-606 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$157.07 - $174.35 $6,596 - $7,322	-42 Reduced 6.48%	606 $100,000
Q3 2020 Nov 13, 2020	BUY	$137.1 - $165.37 $88,840 - $107,159	648 New	648 $107,000
Q1 2020 May 15, 2020	SELL	$92.66 - $144.94 $157,985 - $247,122	-1,705 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$116.25 - $133.25 $178,443 - $204,538	-1,535 Reduced 47.38%	1,705 $226,000
Q3 2019 Nov 13, 2019	SELL	$112.57 - $128.43 $24,202 - $27,612	-215 Reduced 6.22%	3,240 $404,000
Q2 2019 Aug 07, 2019	BUY	$97.98 - $114.28 $338,520 - $394,837	3,455 New	3,455 $392,000
Q1 2019 May 15, 2019	SELL	$81.56 - $100.67 $95,833 - $118,287	-1,175 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$79.28 - $95.27 $93,154 - $111,942	1,175 New	1,175 $101,000
Q2 2018 Aug 13, 2018	SELL	$79.9 - $89.2 $415,480 - $463,840	-5,200 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$71.51 - $84.69 $371,852 - $440,388	5,200 New	5,200 $434,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of C M Bidwell & Associates LTD, based on Form 13F filings with the SEC.

Stay updated on C M Bidwell & Associates LTD with notifications on news.